Skip to main content
. 2019 May 21;4(7):659–669. doi: 10.1001/jamacardio.2019.1776

Figure 1. Trial Profile.

Figure 1.

Information on the number of patients treated with drug-eluting stents during the period of study enrollment is given irrespective of whether these patients fulfilled the inclusion and exclusion criteria because we do not have reliable data on the total number of eligible patients. EES indicates everolimus-eluting stent; SES, sirolimus-eluting stent; ZES, zotarolimus-eluting stent.